In these situations, hyperglycolytic ECs produce lactate but still take up extracellular lactate via MCT1, thereby promoting tumor angiogenesis and the EndoMT or impairing endothelial barrier function.9, 10, 13. The gene discussed is SLC16A1; the disease is neoplasm.